Cabungcag, Zhellian .

HRN: 21-73-26  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/24/2023
CEFTRIAXONE 1G (VIAL)
08/24/2023
08/30/2023
IVTT
1.2grams
Q24h
T/C UTI, T/C Dengue Fever With WS, ARTI
Waiting Final Action 

Indication:  Empiric    Type of Infection:  URTIBloodstreamIntra-abdominalMultiple Infections (tick All Sites)    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: